Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug trial aims to protect unborn babies from Life-Threatening bleeding

NCT ID NCT06533098

Recruiting now Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational drug called nipocalimab works better than the current standard treatment (IVIG) to prevent severe bleeding and low platelet counts in babies at risk of a rare immune condition called FNAIT. It will enroll about 50 pregnant women who have had a previous pregnancy affected by FNAIT. The goal is to see if nipocalimab can more effectively control the disease and improve outcomes for both mother and baby.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Advocate Children's Hospital

    RECRUITING

    Park Ridge, Illinois, 60068, United States

  • Birmingham Women's Hospital

    RECRUITING

    Birmingham, B15 2TG, United Kingdom

  • Childrens Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

  • Hospital of the University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Instytut Centrum Zdrowia Matki Polki

    RECRUITING

    Lodz, 93 338, Poland

  • Instytut Matki i Dziecka

    RECRUITING

    Warsaw, 01 211, Poland

  • John Radcliffe Hospital

    RECRUITING

    Oxford, OX3 9DU, United Kingdom

  • Leiden University Medical Center

    RECRUITING

    Leiden, 2333 ZA, Netherlands

  • Liverpool Women's NHS Foundation Trust - Liverpool Women's Hospital

    RECRUITING

    Liverpool, L8 7SS, United Kingdom

  • Medical University Vienna

    RECRUITING

    Vienna, 1090, Austria

  • Medizinische Hochschule Hannover

    RECRUITING

    Hanover, 30625, Germany

  • Medizinische Universitaet Graz

    RECRUITING

    Graz, 8036, Austria

  • Panstwowy Instytut Medyczny MSWiA w Warszawie

    RECRUITING

    Warsaw, 02 507, Poland

  • Queen Charlotte's and Chelsea Hospital

    RECRUITING

    London, W12 0HS, United Kingdom

  • The University of Alabama at Birmingham

    RECRUITING

    Birmingham, Alabama, 35205, United States

  • UC Davis School of Medicine

    RECRUITING

    Sacramento, California, 95817, United States

  • Universitaetsklinikum Giessen und Marburg GmbH

    RECRUITING

    Giessen, 35392, Germany

  • Universitaetsklinikum Tuebingen

    RECRUITING

    Tübingen, 72076, Germany

  • Universitatsklinikum Jena

    RECRUITING

    Jena, 07747, Germany

  • University of Cincinnati

    RECRUITING

    Cincinnati, Ohio, 45267, United States

  • University of North Carolina at Chapel Hill

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

  • University of Texas Medical Branch

    RECRUITING

    Galveston, Texas, 77555, United States

Conditions

Explore the condition pages connected to this study.

THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE